About GenoPalate
GenoPalate is a private company based in Milwaukee, Wisconsin. It has reported $15,363,571 raised in seven offerings on Form D since March 2018. Its chief executive is Asif Naseem.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | Mar 4, 2026 | $250,000of $3.0M target | 1 | $250K | EquityRule 506(b) | Form D ↗ |
| Oct 3, 2024 | Dec 10, 2024 | $3,000,000of $10.0M target | 4 | $750K | EquityRule 506(b) | Form D ↗ |
| Oct 7, 2022 | Oct 21, 2022 | $6,047,456of $11.0M target | 6 | $1.0M | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 15, 2020 | Dec 29, 2020 | $3,999,955fully sold | 9 | $444K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 2, 2019 | Dec 16, 2019 | $1,000,000of $3.0M target | 1 | $1.0M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 19, 2018 | Dec 3, 2018 | $709,095of $1.5M target | 8 | $88,637 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 19, 2018 | Mar 30, 2018amended May 3, 2018 | $357,065fully sold | 6 | $59,511 | Equity, DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Total, seven offerings | $15,363,571 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GenoPalate's Form D filed Mar 4, 2026.
JS
Joseph Smith
Director
YZ
Yi Zhang
Director
AN
JB
John Byrnes
Director
HS
Harald Steltzer
Director
MM
Michael McNally
Executive officer
Earlier filings also listed Dennis Hodges (executive officer, last listed Oct 2022), Chad Raube (director, last listed Oct 2022), Bradley Simmons (director, last listed Oct 2022) and Brian Gagne (executive officer, last listed Dec 2020).